Subsequently, we determined MAGE-A9 protein expression in ovarian epithelial tumor samples and analyzed the correlation between MAGE-A9 and other clinicopathologic features in a group of patients with EOC. This evidence concerns the gene MAGEA9 and ovarian epithelial tumor.